Jason Brown

Jason Brown is an accomplished executive in the biotech and pharmaceutical industries, currently serving as Chief Business Officer at IMU Biosciences since September 2024, where the focus is on building strategic partnerships to enhance disease diagnosis and patient monitoring. Prior to this role, Jason held the position of Senior Vice President of Business Development at Evotec, facilitating drug discovery partnerships through advanced integrated platforms. Jason co-founded Ubiquigent Ltd, contributing as a Board Member and Director, while earlier experience includes leadership roles in both business development and assay development at various biotech companies, including Pfizer and GlaxoSmithKline. Educationally, Jason holds a PhD and MPhil in Molecular Biochemistry from the University of Cambridge, underscoring a strong foundation in biological sciences.